Finance

Lists
INMB:NASDAQ
INmune Bio Inc
$2.18
-2.47%
(-0.055) 1D
Aug 20, 2:52:11 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INMB...
Open
$2.20
High
$2.24
Low
$2.14
Mkt. cap
60.09M
Avg. vol.
508.99K
Volume
300.32K
52-wk high
$2.44
52-wk low
$1.09
EPS
-$0.69
Beta
0.97
Shares outstanding
27.75M
No. of employees
21
Open
$2.20
High
$2.24
Low
$2.14
Mkt. cap
60.09M
Avg. vol.
508.99K
Volume
300.32K
52-wk high
$2.44
52-wk low
$1.09
EPS
-$0.69
Beta
0.97
Shares outstanding
27.75M
No. of employees
21
News stories
From web sources and news partners
About INmune Bio Inc
CEO-
Employees21
Founded2015
HeadquartersBoca Raton, Florida, United States
SectorBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to INMB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INMB in the last 3 months
Highest
Current $2.18
$8.00 (+267.82%)
Average
$8.00 (+267.82%)
Lowest
$8.00 (+267.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+267.8%
08/11/2026
James Molloy
Alliance Global Partners
Buy
Maintained
$7.00
+221.8%
04/06/2026
Elemer Piros
Lucid Capital
Buy
Upgraded
$9.00
+313.8%
03/11/2026
Thomas Shrader
BTIG
Hold
Maintained
-
-
11/03/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.75M
2.56M
3.64M
-803.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.68M
2.92M
2.17M
2.28M
Operating expense
7.43M
5.47M
5.81M
1.48M
Total operating expenses
7.43M
5.47M
5.81M
1.48M
Operating income
-7.43M
-5.47M
-5.81M
-1.48M
Other non operating income
-39.00K
-90.00K
405.00K
3.00K
EBT including unusual items
-6.47M
-5.26M
-5.41M
-1.27M
EBT excluding unusual items
-7.07M
-5.26M
-5.41M
-1.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.47M
-5.26M
-5.41M
-1.27M
Net profit margin
-
-
-
-
Earnings per share
-0.24
-0.18
-0.20
-0.05
Interest and investment income
400.00K
300.00K
-
200.00K
Interest expense
-
-
-
-
Net interest expenses
400.00K
300.00K
-
200.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.42M
-5.42M
-5.76M
-1.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps